These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 27543214
1. Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. Lawrence NF, Hammond MR, Frederick DT, Su Y, Dias-Santagata D, Deng A, Selim MA, Mahalingam M, Flaherty KT, Hoang MP. J Am Acad Dermatol; 2016 Sep; 75(3):595-602. PubMed ID: 27543214 [Abstract] [Full Text] [Related]
2. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver? Kadokura A, Frydenlund N, Leone DA, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M. Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030 [Abstract] [Full Text] [Related]
3. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Straume O, Sviland L, Akslen LA. Clin Cancer Res; 2000 May; 6(5):1845-53. PubMed ID: 10815907 [Abstract] [Full Text] [Related]
4. Neurotrophin receptors and perineural invasion in desmoplastic melanoma. Frydenlund N, Leone DA, Mitchell B, Yang S, Deng A, Hoang MP, Mahalingam M. J Am Acad Dermatol; 2015 May; 72(5):851-8. PubMed ID: 25752716 [Abstract] [Full Text] [Related]
10. Gene expression profiling of primary cutaneous melanoma and clinical outcome. Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer. J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783 [Abstract] [Full Text] [Related]
13. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O. Cancer; 1997 Sep 15; 80(6):1034-45. PubMed ID: 9305703 [Abstract] [Full Text] [Related]
14. Prognostic prediction of the immunohistochemical expression of p16 and p53 in cutaneous melanoma: a comparison of two populations from different geographical regions. Sirigu P, Piras F, Minerba L, Murtas D, Maxia C, Colombari R, Corbu A, Perra MT, Ugalde J. Eur J Histochem; 2006 Sep 15; 50(3):191-8. PubMed ID: 16920642 [Abstract] [Full Text] [Related]
15. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. Zlotta AR, Noel JC, Fayt I, Drowart A, Van Vooren JP, Huygen K, Simon J, Schulman CC. J Urol; 1999 Mar 15; 161(3):792-8. PubMed ID: 10022686 [Abstract] [Full Text] [Related]